Trial Profile
Does therapy with an inhaled combination of fluticasone and salmeterol improve clinical outcomes and compliance with taking asthma medication in patients with asthma?
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 25 Aug 2023
Price :
$35
*
At a glance
- Drugs Salmeterol/fluticasone propionate (Primary) ; Fluticasone propionate; Salmeterol
- Indications Asthma
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline; GSK
- 05 Apr 2012 Official Title amended as reported by Australian New Zealand Clinical Trials Registry record.
- 05 Apr 2012 Actual initiation date changed from May 2006 to Feb 2007 as reported by Australian New Zealand Clinical Trials Registry record.
- 29 Aug 2011 Actual initiation date Mar 2006 added as reported by Australian New Zealand Clinical Trials Registry.